TL;DR: Women’s Heart Health Risks Often Missed by CAC Scores
A coronary artery calcium (CAC) score of zero may not fully reflect heart disease risks in women, especially premenopause. Non-calcified plaque, common in women, is invisible in CAC scoring but can still lead to heart attacks.
• Women develop softer, non-calcified plaques that CAC scores miss, unlike men.
• Advanced imaging like coronary CT angiography (CCTA) better detects these risks.
• Postmenopausal women may see risks increase due to delayed calcification detection.
Consult your doctor to explore advanced imaging and comprehensive risk assessments beyond CAC scores to safeguard heart health.
You might believe a coronary artery calcium (CAC) score of zero is a golden ticket to cardiovascular health, but research reveals a different reality for many women. For decades, CAC scoring has been hailed as a simple and effective tool for assessing heart disease risk. By measuring calcified plaque in the arteries, physicians could predict future cardiovascular events with surprising accuracy. However, recent studies show this method falls short when evaluating women’s heart health, especially before menopause.
Let’s uncover why CAC scores in women might not tell the full story, and how a zero score might overlook critical risks.
Is a CAC Score of Zero Reliable for Women?
Here’s the key issue: coronary artery calcium scoring primarily detects hardened, calcified plaque in the arteries. While this approach works well for men, it’s less reliable for women. Women often develop non-calcified plaque, which is softer, lipid-rich, and harder to detect with standard calcium scoring. This type of plaque is more prone to rupture, leading to heart attacks or strokes.
Research published in the European Heart Journal emphasizes how women, even with zero CAC, may carry significant risk because calcification tends to lag by approximately 10 years. This means a lower detectable score doesn’t necessarily mean lower cardiovascular risk, especially if they have elevated biomarkers like apoB, diabetes, or high blood pressure.
How Do Women’s Heart Risks Differ from Men’s?
Women experience heart disease differently. While men are more likely to have calcified plaques that CAC scoring easily detects, women often have non-calcified plaque. According to studies like the one conducted by the Multi-Ethnic Study of Atherosclerosis (MESA), 62% of middle-aged women had a CAC score of zero, compared to just 40% of men in the same study. Though reassuring in theory, researchers found many of these women still carried markers of cardiovascular risk.
Furthermore, women’s heart disease can manifest as plaque erosion rather than rupture, a subtler condition that often escapes detection. This makes advanced imaging, such as coronary CT angiography (CCTA), far more crucial for women with borderline risks.
Why Advanced Imaging Matters
Relying solely on CAC scores may create false security for women at risk of heart disease. Advanced imaging techniques, like coronary CT angiography (CCTA), offer a broader view by revealing non-calcified as well as calcified plaques. While CCTA comes with downsides like higher radiation exposure and the use of contrast dyes, it’s often worth the tradeoff for women whose risk assessment seems inconsistent with their CAC score.
Studies analyzed in 2019 show that high-risk plaque features picked up during CCTA predicted cardiovascular events with nearly eight times higher accuracy in women compared to men. This underscores the unique need for tailored diagnostics in women.
What Should Women Consider Beyond CAC Scoring?
For women assessing heart disease risk, combining CAC scores with a broader range of diagnostics and biometrics provides better insight. Tools like lipid profiling (focusing on apoB), assessing blood pressure trends, and understanding family medical history offer important data points.
Additionally, postmenopausal women should approach zero CAC scores with caution. As estrogen levels drop, calcification becomes more detectable, revealing risks that might not have been visible earlier.
Shifting the Standard in Women’s Heart Health
The limitations of CAC scoring show the need for personalized medicine. While a result of zero can be helpful, it shouldn’t overshadow the broader clinical picture, particularly for women with intermediate risk. One incremental shift includes combining CAC with clinical tools like biomarker evaluations, genetic testing for cardiovascular predisposition, and wearable health tech for continuous monitoring.
Making Informed Choices
Before accepting a zero CAC score as reassurance, consult your doctor about your unique risk factors. If biomarkers or lifestyle indicators suggest higher risk, discuss advanced imaging options like CCTA.
Advocating for nuanced evaluation and combining tools will help women achieve better heart health outcomes, not merely rely on a single score.
Discover More
For tailored insights into improving cardiovascular health, browse reliable sources like Peter Attia MD or explore thorough diagnostics at your next health check-up. For Malta-based initiatives promoting wellness and longevity, learn about MELA AI and connect with local restaurants that prioritize healthy, heart-conscious dining.
FAQs on Coronary Artery Calcium (CAC) Scoring and Women’s Cardiovascular Health
Why is CAC scoring less reliable for women than for men?
CAC scoring detects calcified plaque in the arteries, which is more common in men. Women, especially before menopause, tend to develop non-calcified plaques, softer and harder to detect with CAC scoring. These plaques are lipid-rich and more prone to rupture, increasing the risk of heart attacks and strokes. Calcification levels in women often lag up to 10 years behind men, leading to false reassurance from low or zero CAC scores. For women, additional risk factors like elevated apoB, diabetes, and high blood pressure should be considered alongside a CAC score. Advanced imaging techniques, such as coronary CT angiography (CCTA), may provide more accurate information about plaque composition and cardiovascular risk. For more details, visit Peter Attia’s insights on CAC scoring in women.
How can advanced imaging detect heart issues in women more accurately?
Advanced imaging techniques like coronary CT angiography (CCTA) capture both calcified and non-calcified plaques, offering a more comprehensive view of a woman’s cardiovascular health. Research has shown that CCTA identifies high-risk plaque features in women with nearly eight times greater accuracy than in men. By detecting plaques that CAC scoring misses, CCTA can provide critical information about cardiovascular risk. However, it involves exposure to radiation and contrast dyes, which should be weighed carefully. Learn more about how CCTA changes cardiovascular diagnostics by exploring this publication on coronary imaging.
What should postmenopausal women know about CAC scores?
Postmenopausal women experience a drop in estrogen levels, increasing calcification in arteries. A CAC score of zero before menopause may become falsely reassuring, as calcified plaque only becomes visible later in life. Women’s cardiovascular risks change significantly after menopause, and zero CAC scores should be interpreted cautiously alongside other biometrics like blood pressure and lipid profiles. For more personalized advice, postmenopausal women should consult physicians and discuss advanced diagnostic options.
What role do biomarkers like apoB play in women’s heart health assessments?
ApoB is a key biomarker indicating the number of atherogenic lipoproteins that can cause plaque build-up in arteries. Elevated apoB levels suggest heightened cardiovascular risk, even if a CAC score is zero. Women are particularly vulnerable as non-calcified plaques may still develop and rupture, increasing heart disease risk. Combining apoB measurement with lipid profiling and other health metrics can lead to more accurate risk assessments. Tools that integrate these factors are often recommended for women.
How do coronary artery plaques differ between men and women?
Men tend to develop calcified plaques, which are easily identified by CAC scoring. Women, however, often have non-calcified plaques, which are harder to detect but carry a higher risk of rupture. Additionally, women may experience plaque erosion rather than rupture, making heart disease symptoms subtler and harder to diagnose. Advanced imaging techniques like CCTA are particularly effective in highlighting these differences. Reviews like this 2019 study detail sex-specific discrepancies and imaging solutions.
Is MELA AI helpful for finding heart-healthy dining in Malta?
Absolutely! MELA AI is a platform designed to connect diners with restaurants that prioritize health-conscious dining. If you’re in Malta and looking for heart-healthy meal options, including those emphasizing balanced lipid profiles, MELA AI helps you find establishments committed to lowering cardiovascular risks. The MELA sticker recognizes restaurants that offer healthier meals, designed for individuals seeking optimal well-being through dietary choices.
Can women reduce cardiovascular risks through diet?
A heart-healthy diet combining whole grains, lean proteins, healthy fats, and polyphenol-rich foods, like those found in Mediterranean diets, can lower cardiovascular risks for women. Restaurants recognized by MELA AI in Malta specialize in such dietary approaches. These establishments focus on nutrient-rich meals, catering to women seeking to prevent heart disease through food. Benefits include improved lipid profiles, reduced inflammation, and better long-term heart health.
What should women with intermediate heart disease risks do?
Women at intermediate risk but with zero CAC scores should not rely solely on CAC scoring. Discuss advanced imaging like CCTA with your doctor, and ensure biomarkers, genetic predispositions, and lifestyle factors are part of your overall risk assessment. Especially pre-menopausal women with borderline risks may benefit from more tailored diagnostics, combining CAC evaluation with imaging and biometrics for accuracy.
Why should restaurant owners in Malta join MELA AI?
MELA AI offers restaurants in Malta and Gozo the opportunity to highlight their commitment to healthy dining. By applying for a MELA sticker, restaurants can attract health-conscious locals and tourists. MELA also provides branding packages, data-driven insights, and targeted strategies, making it easier for businesses to promote their nutritious offerings to diners seeking quality and well-being. For more information on boosting your restaurant’s reputation through health focus, explore the MELA AI platform.
How can diners in Malta identify restaurants focused on cardiovascular health?
The MELA AI directory is your go-to resource for locating restaurants that offer heart-healthy dining options in Malta and Gozo. By searching for establishments that focus on nutrient-rich meals, you can align food choices with cardiovascular health goals. Look for the MELA sticker, which recognizes restaurants dedicated to offering balanced, health-promoting meals tailored to diverse dietary needs. Whether you’re managing high cholesterol, diabetes, or simply seeking nutritious options, MELA AI ensures transparency in dining.
About the Author
Violetta Bonenkamp, also known as MeanCEO, is an experienced startup founder with an impressive educational background including an MBA and four other higher education degrees. She has over 20 years of work experience across multiple countries, including 5 years as a solopreneur and serial entrepreneur. Throughout her startup experience she has applied for multiple startup grants at the EU level, in the Netherlands and Malta, and her startups received quite a few of those. She’s been living, studying and working in many countries around the globe and her extensive multicultural experience has influenced her immensely.
Violetta Bonenkamp’s expertise in CAD sector, IP protection and blockchain
Violetta Bonenkamp is recognized as a multidisciplinary expert with significant achievements in the CAD sector, intellectual property (IP) protection, and blockchain technology.
CAD Sector:
- Violetta is the CEO and co-founder of CADChain, a deep tech startup focused on developing IP management software specifically for CAD (Computer-Aided Design) data. CADChain addresses the lack of industry standards for CAD data protection and sharing, using innovative technology to secure and manage design data.
- She has led the company since its inception in 2018, overseeing R&D, PR, and business development, and driving the creation of products for platforms such as Autodesk Inventor, Blender, and SolidWorks.
- Her leadership has been instrumental in scaling CADChain from a small team to a significant player in the deeptech space, with a diverse, international team.
IP Protection:
- Violetta has built deep expertise in intellectual property, combining academic training with practical startup experience. She has taken specialized courses in IP from institutions like WIPO and the EU IPO.
- She is known for sharing actionable strategies for startup IP protection, leveraging both legal and technological approaches, and has published guides and content on this topic for the entrepreneurial community.
- Her work at CADChain directly addresses the need for robust IP protection in the engineering and design industries, integrating cybersecurity and compliance measures to safeguard digital assets.
Blockchain:
- Violetta’s entry into the blockchain sector began with the founding of CADChain, which uses blockchain as a core technology for securing and managing CAD data.
- She holds several certifications in blockchain and has participated in major hackathons and policy forums, such as the OECD Global Blockchain Policy Forum.
- Her expertise extends to applying blockchain for IP management, ensuring data integrity, traceability, and secure sharing in the CAD industry.
Violetta is a true multiple specialist who has built expertise in Linguistics, Education, Business Management, Blockchain, Entrepreneurship, Intellectual Property, Game Design, AI, SEO, Digital Marketing, cyber security and zero code automations. Her extensive educational journey includes a Master of Arts in Linguistics and Education, an Advanced Master in Linguistics from Belgium (2006-2007), an MBA from Blekinge Institute of Technology in Sweden (2006-2008), and an Erasmus Mundus joint program European Master of Higher Education from universities in Norway, Finland, and Portugal (2009).
She is the founder of Fe/male Switch, a startup game that encourages women to enter STEM fields, and also leads CADChain, and multiple other projects like the Directory of 1,000 Startup Cities with a proprietary MeanCEO Index that ranks cities for female entrepreneurs. Violetta created the “gamepreneurship” methodology, which forms the scientific basis of her startup game. She also builds a lot of SEO tools for startups. Her achievements include being named one of the top 100 women in Europe by EU Startups in 2022 and being nominated for Impact Person of the year at the Dutch Blockchain Week. She is an author with Sifted and a speaker at different Universities. Recently she published a book on Startup Idea Validation the right way: from zero to first customers and beyond, launched a Directory of 1,500+ websites for startups to list themselves in order to gain traction and build backlinks and is building MELA AI to help local restaurants in Malta get more visibility online.
For the past several years Violetta has been living between the Netherlands and Malta, while also regularly traveling to different destinations around the globe, usually due to her entrepreneurial activities. This has led her to start writing about different locations and amenities from the POV of an entrepreneur. Here’s her recent article about the best hotels in Italy to work from.
